Prostate Cancer
A urologic oncology roundtable discussion: Issues to consider in choosing treatment for metastatic castration-resistant prostate cancer - Abstract
November 19, 2013
Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy - Abstract
November 18, 2013
Permanent prostate brachytherapy extracapsular radiation dose distributions: Analysis of a multi-institutional database - Abstract
November 18, 2013
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy - Abstract
November 18, 2013
External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy - Abstract
November 18, 2013
Regional variation in quality of prostate cancer care - Abstract
November 18, 2013
Robust plan optimization for electromagnetic transponder guided hypo-fractionated prostate treatment using volumetric modulated arc therapy - Abstract
November 18, 2013
Cancer-associated bone disease - Abstract
November 18, 2013
Algeta ASA: Xofigo® (radium Ra 223 dichloride) granted marketing authorization in the European Union
November 15, 2013
Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy - Abstract
November 15, 2013
Post-radical prostatectomy predictive factors for biochemical recurrence - Abstract
November 15, 2013
Diagnosis and multimodal therapy for extragastrointestinal stromal tumor of the prostate: A case report - Abstract
November 15, 2013
Complete regression of advanced prostate cancer for ten years: A case report and review of the literature - Abstract
November 15, 2013